Sun CX, Robb VA, Gutmann DH: Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J Cell Sci. 2002, 115: 3991-4000. 10.1242/jcs.00094.
Article
CAS
PubMed
Google Scholar
Calinisan V, Gravem D, Chen RPH, Brittin S, Mohandas N, Lecomte MC, Gascard P: New insights into potential functions for the protein 4.1 superfamily of proteins in kidney epithelium. Front Biosci. 2006, 11: 1646-66. 10.2741/1911.
Article
CAS
PubMed
Google Scholar
Parra M, Gascard P, Walensky LD, Gimm JA, Blackshaw S, Chan N, Takakuwa Y, Berger T, Lee G, Chasis JA, Snyder SH, Mohandas N, Conboy JG: Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J Biol Chem. 2000, 275: 3247-55. 10.1074/jbc.275.5.3247.
Article
CAS
PubMed
Google Scholar
Hanada T, Takeuchi A, Sondarva G, Chishti AH: Protein 4.1-mediated membrane targeting of human discs large in epithelial cells. J Biol Chem. 2003, 278: 34445-50. 10.1074/jbc.M305209200.
Article
CAS
PubMed
Google Scholar
Bernkopf DB, Williams ED: Potential role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer. Expert Opin Ther Targets. 2008, 12: 845-53. 10.1517/14728222.12.7.845.
Article
CAS
PubMed
Google Scholar
Schulz WA, Alexa A, Jung V, Hader C, Hoffmann MJ, Yamanaka M, Fritzsche S, Wlazlinski A, Müller M, Lengauer T, Engers R, Florl AR, Wullich B, Rahnenführer J: Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol Cancer. 2007, 6: 14-10.1186/1476-4598-6-14.
Article
PubMed
PubMed Central
Google Scholar
Wong SY, Haack H, Kissil JL, Barry M, Bronson RT, Shen SS, Whittaker CA, Crowley D, Hynes RO: Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci USA. 2007, 104: 12784-9. 10.1073/pnas.0705499104.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shimizu K, Nagamachi Y, Tani M, Kimura K, Shiroishi T, Wakana S, Yokota J: Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics. 2000, 65: 113-20. 10.1006/geno.2000.6154.
Article
CAS
PubMed
Google Scholar
Chauhan S, Pandey R, Way JF, Sroka TC, Demetriou MC, Kunz S, Cress AE, Mount DW, Miesfeld RL: Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation. Biochem Biophys Res Commun. 2003, 310: 421-32. 10.1016/j.bbrc.2003.08.147.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, Cai Y, Penland R, Chauhan S, Miesfeld RL, Ittmann M: Increased expression of the metastasis-associated gene Ehm2 in prostate cancer. Prostate. 2006, 66: 1641-52. 10.1002/pros.20474.
Article
CAS
PubMed
Google Scholar
Laprise P, Lau KM, Harris KP, Silva-Gagliardi NF, Paul SM, Beronja S, Beitel GJ, McGlade CJ, Tepass U: Yurt, Coracle, Neurexin IV and the Na(+), K(+)-ATPase form a novel group of epithelial polarity proteins. Nature. 2009, 459: 1141-5. 10.1038/nature08067.
Article
CAS
PubMed
Google Scholar
Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A, Flores-Morales A: Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem. 2006, 281: 29938-48. 10.1074/jbc.M602237200.
Article
CAS
PubMed
Google Scholar
Chuan YC, Iglesias-Gato D, Fernandez-Perez L, Cedazo-Minguez A, Pang ST, Norstedt G, Pousette A, Flores-Morales A: Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene. 2010, 29: 1531-42. 10.1038/onc.2009.442.
Article
CAS
PubMed
Google Scholar
Lutchman M, Pack S, Kim AC, Azim A, Emmert-Buck M, van Huffel C, Zhuang Z, Chishti AH: Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression. Cancer Genet Cytogenet. 1999, 115: 65-9. 10.1016/S0165-4608(99)00081-3.
Article
CAS
PubMed
Google Scholar
Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009, 9: 265-73. 10.1038/nrc2620.
Article
CAS
PubMed
Google Scholar
Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139: 871-90. 10.1016/j.cell.2009.11.007.
Article
CAS
PubMed
Google Scholar
Kumar-Sinha C, Tomlins SA, Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008, 8: 497-511. 10.1038/nrc2402.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hermans KG, Bressers AA, van der Korput HA, Dits NF, Jenster G, Trapman J: Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Cancer Res. 2008, 68: 3094-8. 10.1158/0008-5472.CAN-08-0198.
Article
CAS
PubMed
Google Scholar
Wang J, Cai Y, Yu W, Ren C, Spencer DM, Ittmann M: Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. Cancer Res. 2008, 68: 8516-24. 10.1158/0008-5472.CAN-08-1147.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2009, 41: 619-24. 10.1038/ng.370.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, Collins C, Bismar TA, Chinnaiyan AM, De Marzo AM, Rubin MA: TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007, 31: 882-8. 10.1097/01.pas.0000213424.38503.aa.
Article
PubMed
Google Scholar
Florl AR, Steinhoff C, Müller M, Seifert HH, Hader C, Engers R, Ackermann R, Schulz WA: Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer. 2004, 91: 985-94.
CAS
PubMed
PubMed Central
Google Scholar
Hoffmann MJ, Müller M, Engers R, Schulz WA: Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. Biochem Pharmacol. 2006, 72: 1577-88. 10.1016/j.bcp.2006.06.020.
Article
CAS
PubMed
Google Scholar
Tomlins SA, Bjartell A, Chinnaiyan AM, Jenster G, Nam RK, Rubin MA, Schalken JA: ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol. 2009, 56: 275-86. 10.1016/j.eururo.2009.04.036.
Article
CAS
PubMed
Google Scholar
Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, Müller M, Schulz WA: Downregulation of several fibulin genes in prostate cancer. Prostate. 2007, 67: 1770-80. 10.1002/pros.20667.
Article
CAS
PubMed
Google Scholar
Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L, Ekman P: Expression of ezrin in prostatic intraepithelial neoplasia. Urology. 2004, 63: 609-12. 10.1016/j.urology.2003.09.068.
Article
PubMed
Google Scholar
Valdman A, Fang X, Pang ST, Nilsson B, Ekman P, Egevad L: Ezrin expression in prostate cancer and benign prostatic tissue. Eur Urol. 2005, 48: 852-7. 10.1016/j.eururo.2005.03.013.
Article
CAS
PubMed
Google Scholar
Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1998, 7: 531-6.
CAS
PubMed
Google Scholar
Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG: Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004, 64: 1975-86. 10.1158/0008-5472.CAN-03-3972.
Article
CAS
PubMed
Google Scholar
King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, Taylor BS, Sander C, Cardiff RD, Couto SS, Gerald WL, Sawyers CL: Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet. 2009, 41: 524-6. 10.1038/ng.371.
Article
CAS
PubMed
PubMed Central
Google Scholar
Norris JD, Chang CY, Wittmann BM, Kunder RS, Cui H, Fan D, Joseph JD, McDonnell DP: The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell. 2009, 36: 405-16. 10.1016/j.molcel.2009.10.020.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cookson MS, Reuter VE, Linkov I, Fair WR: Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol. 1997, 157: 673-6. 10.1016/S0022-5347(01)65248-0.
Article
CAS
PubMed
Google Scholar
Schulz WA, Hatina J: Epigenetics of prostate cancer: beyond DNA methylation. J Cell Mol Med. 2006, 10: 100-25. 10.1111/j.1582-4934.2006.tb00293.x.
Article
CAS
PubMed
Google Scholar
Tan JS, Mohandas N, Conboy JG: Evolutionarily conserved coupling of transcription and alternative splicing in the EPB41 (protein 4.1R) and EPB41L3 (protein 4.1B) genes. Genomics. 2005, 86: 701-7. 10.1016/j.ygeno.2005.08.005.
Article
CAS
PubMed
Google Scholar